HHS contracts to develop new Ebola drug

HHS contracts to develop new Ebola drug

Work will prepare for large-scale drug manufacturing

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded approximately $12 million today to BioCryst Pharmaceuticals of Durham, North Carolina, for the advanced development of a promising experimental drug for Ebola, including preparing for large-scale manufacturing of the drug and conducting related studies.

Read more about today's announcement.